Kumar Singh Saikatendu
Senior Director
Kumar Singh Saikatendu
Takeda Pharmaceuticals
Senior Director
- Ph.D Molecular Biophysics; Indian Institute of Science, Bangalore India 2001
- Post Doc research: 2001-2004 Univ. Texas Southwestern Medical Center Dallas TX. USA
- Sr. Research Associate 2004-2008 The Scripps Research Institute La Jolla, CA, USA
- Takeda Pharmaceuticals 2008 – present. Currently serving as Head of Takeda’s Lipid nanoparticle platform in Drug Discovery Sciences team; Board of Directors of Structural Genomics Consortium; Project Co-Lead of IMI-CARE consortium – EU’s largest COVID research consortium.